58584-86-4 Usage
Description
2,6-Dichloronicotinic acid ethyl ester is a chemical compound that belongs to the class of organic compounds known as pyridines and derivatives. It contains chlorine and has a molecular formula of C8H7Cl2NO2, indicating the presence of 8 carbon atoms, 7 hydrogen atoms, 2 chlorine atoms, one nitrogen atom, and 2 oxygen atoms. 2,6-Dichloronicotinic acid ethyl ester is primarily used as an intermediate in the synthesis of other chemical compounds, particularly in the pharmaceutical industry. It is generally available in liquid form and should be handled with care due to potential hazards associated with its use.
Uses
Used in Pharmaceutical Industry:
2,6-Dichloronicotinic acid ethyl ester is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its role in the industry is crucial as it aids in the production of a wide range of medications, contributing to the development and availability of essential drugs for treating various health conditions.
Used in Chemical Synthesis:
2,6-Dichloronicotinic acid ethyl ester is used as a key component in the synthesis of other chemical compounds. Its unique structure and properties make it a valuable building block for creating a diverse array of chemical products, including those used in various industries such as agriculture, manufacturing, and research.
Check Digit Verification of cas no
The CAS Registry Mumber 58584-86-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,8 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 58584-86:
(7*5)+(6*8)+(5*5)+(4*8)+(3*4)+(2*8)+(1*6)=174
174 % 10 = 4
So 58584-86-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H7Cl2NO2/c1-2-13-8(12)5-3-4-6(9)11-7(5)10/h3-4H,2H2,1H3
58584-86-4Relevant articles and documents
Boron-Containing Small Molecules as Anti-Inflammatory Agents
-
Paragraph 0722-0723, (2015/11/16)
Compounds and methods of treating anti-inflammatory conditions are disclosed.
4, 5-DIHYDRO-LH-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES
-
Page/Page column 65, (2010/11/03)
Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.
NEW PYRIDINE ANALOGUES VIII 518
-
Page/Page column 184-185, (2008/12/07)
The present invention relates to certain new pyridin analogues of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
